Published in
Elsevier, Applied Radiation and Isotopes, (123), p. 109-113, 2017
DOI: 10.1016/j.apradiso.2017.02.024
Links
Tools
Preclinical evaluation of 131 I-Bevacizumab – A prospective agent for radioimmunotherapy in VEGF expressing cancers
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 